about
Characterization of inducible models of Tay-Sachs and related diseaseStat3 controls cell death during mammary gland involution by regulating uptake of milk fat globules and lysosomal membrane permeabilizationSignal transducer and activator of transcription 3 and the phosphatidylinositol 3-kinase regulatory subunits p55α and p50α regulate autophagy in vivo.Immunocytochemical Evidence for Golgi Vesicle Involvement in Milk Fat Globule Secretion.TNF, acting through inducibly expressed TNFR2, drives activation and cell cycle entry of c-Kit+ cardiac stem cells in ischemic heart disease.Opioidergic regulation of astroglial/neuronal proliferation: where are we now?A 3-D in vitro co-culture model of mammary gland involution.Endo-lysosomal and autophagic dysfunction: a driving factor in Alzheimer's disease?Commentary: Possible involvement of lysosomal dysfunction in pathological changes of the brain in aged progranulin-deficient miceAcute in utero morphine exposure slows G2/M phase transition in radial glial and basal progenitor cells in the dorsal telencephalon of the E15.5 embryonic mouse.Mu opioid receptors are expressed on radial glia but not migrating neuroblasts in the late embryonic mouse brain.A novel fluorescent probe reveals starvation controls the commitment of amyloid precursor protein to the lysosome.Reduction in open field activity in the absence of memory deficits in the AppNL-G-F knock-in mouse model of Alzheimer's disease.Analysis of the Involuting Mouse Mammary Gland: An In Vivo Model for Cell Death.Stat3 mediated alterations in lysosomal membrane protein composition.Lysosomal LAMP1 immunoreactivity exists in both diffuse and neuritic amyloid plaques in the human hippocampus.Retromer has a selective function in cargo sorting via endosome transport carriersAutophagy Modulation as a Treatment of Amyloid DiseasesGenetic variation within endolysosomal system is associated with late-onset Alzheimer's diseaseRapamycin and Alzheimer disease: a double-edged sword?Lysosomal Dysregulation in the Murine AppNL-G-F/NL-G-F Model of Alzheimer's Disease
P50
Q27331703-FA6FAABE-DB70-4E53-BE21-83E6EC743A40Q34437556-C9DA6F05-E483-4E7C-998C-F6F48E793C1AQ35190557-9732512A-9673-4CC2-AB1A-B6C650225DD7Q36774491-EA39DDDC-D7A3-45C4-9888-1E29A3D44AF9Q37227430-5AAC694B-FDC3-4A5E-85C6-3632EA1AB6C9Q37266683-D8B7461C-8DC6-4D14-9908-5C1515DC965BQ39005382-6A3226BE-452A-4684-AA17-AB7695CEFAF2Q39058736-F8A7DF74-97B0-4AEF-906E-A60D07F147FDQ42041942-3916A632-402E-4702-B9A1-73C0BF0F0A58Q42441484-F19D4927-E2D1-408C-94DC-0B30B91231BEQ44336323-217AFAC8-6962-43B4-BB61-FC0B4B8E61E9Q46345864-2C065D96-5F46-4BA5-BA51-35EAC43F4184Q47831897-4FCF13B9-48B4-4629-A424-CB9740D09557Q48507462-994B9379-03CA-442C-A148-E7306B9D68A5Q48533476-34DE5A6B-630F-4F69-A2B7-80BCDC0CB76CQ53396681-AC51D7B8-DA07-4E08-99FB-A7BACCDBC9B1Q63681517-669E9586-EEAF-4C89-8255-9D3A36E775ACQ90133516-A1D44CE2-F020-4D7F-BD43-AD62BD8DD6D0Q91036947-7261031B-10F4-4626-A7EB-CE5F4CE9ABADQ91844324-4A87353C-C227-472B-870E-B310CC52A201Q92515123-E4E26EDA-4536-46E5-B519-980A3E57E5F2
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Timothy J Sargeant
@ast
Timothy J Sargeant
@en
Timothy J Sargeant
@es
Timothy J Sargeant
@nl
type
label
Timothy J Sargeant
@ast
Timothy J Sargeant
@en
Timothy J Sargeant
@es
Timothy J Sargeant
@nl
prefLabel
Timothy J Sargeant
@ast
Timothy J Sargeant
@en
Timothy J Sargeant
@es
Timothy J Sargeant
@nl
P106
P1153
22136421100
P31
P496
0000-0003-1254-4390